Founded in 2002, Prognosis Labs operates in Health Tech offering a range of diagnostic services including cardiology, pathology, and molecular diagnostics. The laboratory features a state-of-the-art f...
Company Type:
Bootstrapped
Revenue:
₹20.7 Cr+ (FY25)
₹20.7 Cr+ (FY25)
Employee count:
79
Last 90d
79
Last 90d
Web traffic:
4.47K
4.47K
Last 30d
Last 30d
Prognosis Labs: Cap Table Highlights
A snapshot of cap table and shareholder metrics
Total Shareholders4
Latest Filing Date26 May 2023- Funding Events3
Event-Based View
Event-Based detailed View by Filings
FAQs on Cap Table of Prognosis Labs
As of 27 May 2023, Prognosis Labs's equity is held by 4 shareholders, with the top three being MedGenome, Deepak Sadwani, and Mayank Madan.
MedGenome holds the largest stake in Prognosis Labs at 70.0% as of 27 May 2023.
As of 27 May 2023, founders collectively hold 18.0% equity in Prognosis Labs.
As of 27 May 2023, investors collectively hold 82.0% equity in Prognosis Labs.
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links